I am putting together an article about how CME providers and commercial supporters can better collaborate in the new regulatory environment for the December issue of Medical Meetings magazine, and would love to get your input.
If you're a CME provider, what do you most want to know from pharma companies about their processes, procedures, and how you can increase your chances of getting educational grants during this time of increased scrutiny, regulation, and enforcement?
If you're with a pharmaceutical company, what do you wish CME providers knew more about so they could work more effectively with you these days?
Please click on the "comments" button below if you have any ideas to share, or e-mail me with your suggestions.
Thanks in advance for any help you can provide!
To receive a weekly update, e-mail Sue.
